Infecciones de transmisión sexual en mujeres en situación de privación de la libertad de un establecimiento penitenciario en Mérida, Venezuela. / Sexually transmitted infections in inmates in Merida Venezuela.
Abstract
Resumen.
Las infecciones de transmisión sexual (ITS) y conductas sexuales de riesgo, son prevalentes en mujeres encarceladas. Este estudio mostró que las ITS fueron más frecuentes en mujeres reclusas (66,6 %) que en mujeres en libertad (p ≤ 0,001). Solo el grupo de encarceladas presentó combinaciones de ITS (39%) (p≤0,019), siendo significativas las infecciones por VPH (p≤ 0,007) y Chlamydia trachomatis (p≤ 0,003) con otros agentes causales. VPH y Chlamydia trachomatis fueron más frecuentes en reclusas (35,7%), mientras que las mujeres libres presentaron 9,5% (p≤0,004) y 7,1% respectivamente (p≤0,001). Las reclusas presentaron combinaciones de diferentes genotipos de VPH (p≤0,011). Las infecciones por Treponema pallidum ocurrieron en 7,1 % en reclusas y estuvieron ausentes en las libres. El virus de la hepatitis B, estuvo presente en un 9,5% de reclusas y ausente en mujeres libres (p≤0,040). Los marcadores para hepatitis C y el virus de la inmunodeficiencia humana (VIH) fueron negativos en ambos grupos; los virus herpes simplex tipo 1 y 2 (VHS) se encontraron en 9,5 % de las reclusas y en 7,1 % de mujeres libres. El consumo de tabaco, alcohol y el uso de otras drogas, mostró una frecuencia de 100%, 89,3% y 78,6% respectivamente en mujeres reclusas y un 40%, 30% y 10% en las libres (p≤0,001). El número de parejas sexuales en relación a la presencia de ITS entre ambos grupos, mostró significancia para un número de dos o más parejas (p<0,006). Se observó una elevada prevalencia de ITS únicas o mixtas en mujeres reclusas, así como factores asociados a conductas sexuales de riesgo.
Abstract.
Sexually transmitted infections (STIs) and sexual risk behaviors are prevalent in incarcerated women. This study showed that STIs were more frequent in female prisoners (66.6%) than in women in freedom (p ≤ 0.001). Only the group of incarcerated women presented a combination of STIs (39%) (p≤0.019), being significant the combination of HPV (p≤ 0.007) and Chlamydia trachomatis (p≤ 0.003) with other causative agents. HPV and Chlamydia trachomatis were more frequent in female prisoners (35.7%), while in non-incarcerated women occurred in 9.5% (p≤0.004) and 7.1%, respectively (p≤0.001). The inmates presented a combination of different HPV genotypes (p≤0.011). Treponema pallidum presented in 7.1% of prisoners and it was negative in free ones. Hepatitis B virus was present in 9.5% of inmates and negative in free women (p≤0.040). Markers for hepatitis C, and human immunodeficiency virus (HIV) were negative in both groups; herpes simplex virus types 1 and 2 (HSV) were found in 9.5% of the inmates and in 7.1% of free women. The consumption of tobacco, alcohol and the use of other drugs showed a frequency of 100%, 89.3% and 78.6%, respectively, of female prisoners and of 40%, 30% and 10% in free women (p≤0.001). The number of sexual partners in relation to the presence of STIs between both groups showed significance for a number of two or more partners (p <0.006). A high prevalence of single or mixed STIs was observed in female prisoners, as well as factors associated with risky sexual behaviors.
Downloads
References
Organización Mundial de la Salud. Infecciones de transmisión sexual. 2016; Consultado en: [En línea] 2016 [Citado el 18 de agosto del 2019] disponible en: http:// www.who.int/mediacentre/factsheets/ fs110/es/.
Garaycochea M, Pino R, Chávez I, Portilla J, Miraval M, Arguedas E, Linares P, Cabezudo E, Romero S, Espinoza M. Sexually transmitted infections in women living in a prison in Lima, Perú. Rev Peru Med Exp Salud Pública 2013; 30(3):423-427.
Organización Panamericana de la Salud. Guía de atención integral de las Enfermedades de Transmisión Sexual 2011. Consultado en: [En línea] 2011 [Citado el 18 de abril del 2019] disponible en: www.paho.org/ecu/index.php?option=com_ content&view=article&id=512:guia-atencion-integral-infecciones-transmision-sexual-2011&Itemid=9723.
Huneeus A, Schilling A, Fernandez M. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Infection in Chilean Adolescents and Young Adults. J Pediatr Adolesc Gynecol 2018;31(4):411-415.
Spaulding A, Miller J, Trigg B, Braverman P, Lincoln T, Reams P, Staples-Horne M, Sumbry A, Rice D, Satterwhite
C. Screening for sexually transmitted diseases in shortterm correctional institutions: summary of evidence reviewed for the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Sex Transm Dis 2013;40(9):679-684.
Satterwhite C, Newman D, Collins D, Torrone E. Chlamydia screening and positivity in juvenile detention centers, United States, 2009–2011. Women Health 2014;54(8):712-725.
Willers D, Peipert J, Allsworth J, Stein M, Rose J, Clarke J. Prevalence and predictors of sexually transmitted infection among newly incarcerated females. Sex Transm Dis 2008;35(1):68-72.
Steiner A, Haller D, Elger B, Sebo P, Gaspoz J, Wolff H. Chlamydia trachomatis infection in a Swiss prison: a cross sectional study. Swiss Med Wkly 2010;140:w13126.
Correa M, Croda J, Coimbra Motta de Castro A, Maria do Valle Leone de Oliveira S, Pompilio MA, Omizolo de Souza R, Ferreira de Sá Queiroz J, Esther da Silva K, Ko A, Simionatto S. High prevalence of Treponema pallidum infection in Brazilian prisoners. Am J Trop Med Hyg 2017;97(4):1078-1084.
Villarroel M, Montaño K, Flores P, Jeannot E, Flores A, Cossio N, Valencia C, Salcedo A, Jiménez M, Castro R, Gétaz G, Bermúdez H, Wolff H, Gétaz L. Syphilis, human immunodeficiency virus, herpes genital and hepatitis B in a women’s prison in Cochabamba, Bolivia: prevalence and risk factors. Rev Esp Sanid Penit 2018; 20: 47-54.
Hammett T. Sexually transmitted diseases and incarceration. Curr Opin Infect Dis 2009;22:77–81.
Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, Menton S, Menton M, Dietz K, Wallwiener D, Kandolf R, Bültmann B. Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol 2004; 42(7):3176–3184.
Stoltey J, Li Y, Bernstein K, Philip S. Ecological analysis examining the association between census tract level incarceration and reported Chlamydia incidence among female adolescents and young adults in San Francisco. Sex Transm Infect 2015;91(5):370-374.
Nokhodian Z, Yazdani M, Yaran M, Shoaei P, Mirian M, Ataei B, Babak A, Ataie M. Prevalence and risk factors of HIV, syphilis, hepatitis B and C among female prisoners in Isfahan, Iran. Hepat Mon 2012;12(7):442- 447.
Stein M, Caviness C, Anderson B. Incidence of Sexually transmitted infections among hazardously-drinking women following incarceration. Womens Health Issues 2012;22(1):e1-7.
Gabriel G, Burns T, Scott-Ram R, Adlington R, Bansi L. Prevalence of Chlamydia trachomatis and associated risk factors in women inmates admitted to a youth offenders institute in the UK. Int J STD AIDS 2008;19(1):26-29.
Fogel C, Gelaude D, Carry M, Herbst J, Parker S, Scheyette A, Neevel A. Context of risk for HIV and sexually transmitted in- fections among incarcerated women in the South: individual, interpersonal, and societal factors. Women Health 2014;54(8):694- 711.
Williams S, Bryant K. Sexually transmitted infection prevalence among home- less adults in the United States: A systematic literature review. Sex Transm Dis 2018;45(7):494–504.
Bernstein K, Chow J, Ruiz J, Schachter J, Horowitz E, Bunnell R, Bolan G. Chlamydia trachomatis and Neisseria gonorrhoeae infections among men and women entering California prisons. Am J Public Health 2006;96(10):1862-1886.
González C, Canals J, Ortiz M, Muñoz L, Torres M, García Saiz A, Del Amo J. Preva- lence and determinants of highrisk human papillomavirus (HPV) infection and cervical cytological abnormalities in imprisoned women. Epidemiol Infect 2008;136(2):215- 221.
Azbel L, Polonsky M, Wegman M, Shumskaya N, Kurmanalieva A, Asanov A, Wic- kersham J, Dvoriak S, Altice F. Intersecting epidemics of HIV, HCV, and syphilis among soon to be released prisoners in Kyrgyzstan: Implications for prevention and treatment. Int J Drug Policy 2016;37:9-20.
Shew M, Fortenberry J, Tu W, Juliar B, Batteiger B, Qadadri B, Brown D. Association of condon use, sexual behaviors, and sexually transmitted infections with the duration of genital human human papillomavirus infection among adolescent women. Arch Pediatr Adolesc Med 2006;160(2):151-156.
Samoff E, Koumans E, Markowitz L, Sternberg M, Sawyer M, Swan D, Papp J, Black C, Unger E. Association of Chlamydia trachomatis with persistence of highrisk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 2005;162(7):668-675.
Zhu H, Shen Z, Luo H, Zhang W, Zhu X. Chlamydia trachomatis infection associated risk of crvical cancer: A meta analysis. Medicine (Baltimore). 2016;95(13):e3077.
Johnson J, Peabody M, Wechsberg W, Rosen R, Fernandes K, Zlotnick C. Feasibility of an HIV/STI risk reduction program for incarcerated women who have experienced interpersonal violence. J Interpers Violence 2015;30(18):3244-3266.
da Silva E, de Souza A, de Souza T, Tsuha D, Barbieri A. Screening for cervical cancer in imprisoned women in Brazil. PLoS One 2017;12(12):e0187873.
Noska A, Roberts M, Sufrin C, Stein A, Beckwith C, Rich J, Dauria E, Clarke J. History of sex exchange in women with a history of incarceration. J Health Care Poor Underserved 2016;27(2A):149-162.
Kuo C, Rosen R, Zlotnick C, Wechsberg W, Peabody M, Johnson J. Sexual health prevention for incarcerated women: eroticizing safe sex during re-entry to the community. BMJ Sex Reprod Health 2018. pii:bmjsrh-2017-2024.
Khan M, Golin C, Friedman S, Scheidell J, Adimora A, Judon Monk S, Hobbs M, Dockery G, Griffin S, Oza K, Myers D, Hu H, Medina KP, Wohl D. STI/HIV sexual risk behavior and prevalent STI among incar- cerated African American men in commit- ted intimate partnerships: the significance of poverty, mood disorders, and substance use. AIDS Behav 2015;19(8):1478-1490.
Knittel A, Ti A, Schear S, Comfort M. Evidence based recommendations to improve reproductive healthcare for incarcerated women. Int J Prison Health 2017;13(3- 4):200-206.
